Carregant...
Endothelin‐1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial
BACKGROUND AND AIMS: Increased endothelin (ET)‐1 activity may contribute to the complications of cirrhosis and portal hypertension. The aim of this study was to assess the systemic and portal haemodynamic effects of selective ET‐A and ET‐B receptor antagonism in patients with cirrhosis. METHODS: Six...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Group
2006
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1860020/ https://ncbi.nlm.nih.gov/pubmed/16434427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2005.077453 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|